抗血栓治疗在成年人与脱落性冠状动脉疾病:一个系统的审查和网络元分析
Alireza Azarboo1,2, Mohammad Shahabaddin Daneshvar1,2, Alireza Sattari Abroy1,2
1Tehran Heart Center, Cardiovascular Diseases Research Institute, Tehran University of Medical Sciences, North Kargar Ave, Tehran, Iran.
概括
双抗血小板疗法 (DAPT) 是预防冠状动脉脱血 (CAE) 中的主要不良心血管事件 (MACE) 的最有效治疗方法. 阿司匹林单一治疗和抗凝药也显示出好处,但DAPT提供了最好的保护.
科学领域:
- 心脏病学 心脏病学
- 药理学 药理学是指药理学的学科.
- 基于证据的医学是基于证据的医学.
背景情况:
- 冠状动脉脱血 (CAE) 管理通常涉及抗血小板或抗凝剂治疗,以减少主要的不良心血管事件 (MACE).
- 对CAE的最佳抗血栓治疗选择尚不清楚,需要进行比较疗效分析.
研究的目的:
- 评估和比较各种抗血栓治疗在被诊断为冠状动脉解剖症 (CAE) 的成年患者中的疗效.
- 通过系统性审查和网络元分析,确定预防CAE患者MACE的最有效的抗血栓策略.
主要方法:
- 按照PRISMA指导方针进行系统审查和网络元分析 (NMA),并遵守PROSPERO注册的协议.
- 截至2024年10月进行的搜索;两位独立审查员进行的研究选择,数据提取和偏差风险评估.
- 双对分析和NMA比较了不同抗血栓治疗和不治疗的MACE几率.
主要成果:
- 该审查包括5039名患有CAE的成年患者.
- 双重抗血小板治疗 (DAPT) 和阿司匹林单一治疗显著降低了MACE,而不是没有治疗.
- 抗凝药显示出降低MACE的趋势,但没有达到统计学意义;DAPT成为NMA中最有效的干预措施.
结论:
- 双抗血小板治疗 (DAPT) 是预防冠状动脉脱血 (CAE) 患者的MACE最有效的治疗方法,得到了SUCRA值的支持.
- 阿司匹林单一治疗和抗凝治疗也有益,在有效性方面排名低于DAPT.
- 结果提供了基于证据的指导,用于优化CAE管理中的抗血栓策略.
相关概念视频
Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants
1.1K
Oral anticoagulants are vital tools in preventing and treating blood clotting disorders. This diverse class of medications can be categorized as vitamin K antagonists, exemplified by warfarin, and direct thrombin inhibitors (DTIs), such as dabigatran, as well as factor Xa inhibitors, including rivaroxaban.
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
1.1K
Anticoagulant Drugs: Low-Molecular-Weight Heparins
603
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
603
Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors
464
Antiplatelet drugs emerge as frontline defenders against the insidious threat of thromboembolic diseases, where abnormal clots obstruct vital blood vessels. These drugs stand as bulwarks, inhibiting platelet aggregation and clot formation, thereby mitigating the risk of life-threatening conditions like myocardial infarction, coronary artery disease, and thrombotic strokes.
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
464
Imaging Studies for Cardiovascular System I:Echocardiography
293
Cardiac imaging studies encompass a wide range of noninvasive and minimally invasive techniques designed to visualize the heart's structure and function in detail. One such technique is echocardiography, which uses high-frequency ultrasound waves to produce detailed images of the heart, known as echocardiograms.
Indications: Echocardiography is utilized to diagnose heart failure, valve disorders, and myocardial infarction. It also assesses cardiac structures' size, shape, and motion,...
Indications: Echocardiography is utilized to diagnose heart failure, valve disorders, and myocardial infarction. It also assesses cardiac structures' size, shape, and motion,...
293
Electroconvulsive Therapy
22
Electroconvulsive therapy (ECT), or shock therapy, remains a critical biomedical intervention for severe, treatment-resistant depression. While its origins can be traced back to Hippocrates' observations that malaria-induced convulsions alleviated mental illness, modern ECT has evolved significantly from its earlier, more primitive applications. First introduced in 1938 by Ugo Cerletti and his colleagues, ECT involves inducing controlled seizures using electrical currents. In its early...
22
Treatment for Pulmonary Arterial Hypertension: Receptor Tyrosine Kinase Inhibitors and Calcium Channel Blockers
133
Receptor tyrosine kinase inhibitors (TKIs) and calcium channel blockers (CCBs) are two critical categories of drugs employed in the treatment of pulmonary artery hypertension (PAH). PAH is a disease that causes high blood pressure in the pulmonary arteries, resulting in chest pain, fatigue, and shortness of breath.
TKIs, such as imatinib (Gleevec), are particularly effective in tackling the growth and mitogenic factors that become upregulated in PAH patients. These factors contribute to the...
TKIs, such as imatinib (Gleevec), are particularly effective in tackling the growth and mitogenic factors that become upregulated in PAH patients. These factors contribute to the...
133


